Andere talen Ajanta Pharma Limited

Aandelen

AJANTPHARM

INE031B01049

Beurs gesloten - NSE India S.E. Andere beurzen 13:51:17 23-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2.130 ^INR	+1,86%		+0,59%	+2,24%

02/02	Ajanta Pharma boekt meer geconsolideerde nettowinst in fiscaal derde kwartaal	MT
31/01	Transcript : Ajanta Pharma Limited, Q3 2024 Earnings Call, Jan 31, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Ajanta Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit	02/02
Ajanta Pharma Limited Approves Second Interim Dividend for the Year Fiscal Year 2024, Payable on or After 19th February 2024	31/01
Ajanta Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	31/01
Ajanta Pharma Board to Consider Second Interim Dividend for Fiscal 2024	25/01
Ajanta Pharma Limited Provides Earnings Guidance for the Full Year of Fiscal 2024	31-10-23
Ajanta Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	31-10-23
Ajanta Pharma Gets US FDA Nod for Topiramate Extended-Release Capsules	31-08-23
Ajanta Pharma Limited Receives Final Approval from US FDA for Topiram Extended Release Capsules	30-08-23
Ajanta Pharma Logs Increase in Fiscal Q1 Consolidated Profit	28-07-23
Ajanta Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	27-07-23
Ajanta Pharma Board to Consider Interim Dividend for Fiscal 2024	24-07-23
Ajanta Pharma Limited Confirms the Interim Dividend for the Year Ended 31 March 2023	18-07-23
Ajanta Pharma Gets No Observations After US FDA's Inspection of API Facility in Hyderabad, India	26-06-23
Ajanta Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	05-05-23
Ajanta Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023	05-05-23
Tranche Update on Ajanta Pharma Limited's Equity Buyback Plan announced on March 10, 2023.	20-04-23
Ajanta Pharma Limited's Equity Buyback announced on March 10, 2023, has closed with 2,210,500 shares, representing 1.73% for ¥3,149.96 million.	10-04-23
Ajanta Pharma Board OKs Up To INR3.2 Billion Share Buyback	10-03-23
Ajanta Pharma Limited announces an Equity Buyback for 2,210,500 shares, representing 1.73% for INR 3,890 million.	10-03-23
Ajanta Pharma Limited authorizes a Buyback Plan.	10-03-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Ajanta Pharma Limited

Aandelen

AJANTPHARM

INE031B01049

Andere talen

Filters